Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled Trial

Migraine involves 5-10% of children and adolescents. Thirty percent of children with severe migraine attacks have school absence and reduced quality of life that need preventive therapy. The purpose of this randomised control trial study is to compare the effectiveness, safety and the tolerability...

Full description

Bibliographic Details
Main Authors: MohammadKazem Bakhshandeh Bali, Ali Akbar Rahbarimanesh, Manelie Sadeghi, Mostafa Sedighi, Parvaneh Karimzadeh, Mohammad Ghofrani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2015-05-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/4892
id doaj-cabd8466c3eb4ed8b24df759602c16ef
record_format Article
spelling doaj-cabd8466c3eb4ed8b24df759602c16ef2020-11-25T02:50:04ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942015-05-015354845Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled TrialMohammadKazem Bakhshandeh Bali0Ali Akbar Rahbarimanesh1Manelie Sadeghi2Mostafa Sedighi3Parvaneh Karimzadeh4Mohammad Ghofrani5Bahrami Children Hospital, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran.Bahrami Children Hospital, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran.Department of Community Medicine, Research Development Center of Bahrami Children Hospital, Tehran University of Medical Sciences, Tehran, Iran.Department of Pediatrics, Kermanshah University of Medical Sciences, Kermanshah, Iran.Department of Pediatric Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Department of Pediatric Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Migraine involves 5-10% of children and adolescents. Thirty percent of children with severe migraine attacks have school absence and reduced quality of life that need preventive therapy. The purpose of this randomised control trial study is to compare the effectiveness, safety and the tolerability of pregabalin toward Propranolol in migraine prophylaxis of children. From May 2011 to October 2012, 99 children 3-15 years referred to the neurology clinic of Mofid Children's Hospital with a diagnosis of migraine enrolled the study. Patients randomly divided into two groups (A&B). We treated children of group A with capsule of pregabalin as children of group B with tablet of propranolol for at least 8 weeks. In this study, 99 patients were examined that 91 children reached the last stage. The group A consistsed of 46 patients, 12(26.1%) girls, 34 (73.9%) boys and the group B consisted of 45 patients, 14(31.1%) girls, 31 (68.9%) boys. Basis of age, gender, headache onset, headache frequency, migraine type, triggering and relieving factors there was no significant difference among these groups (P>0.05). After 4 and 8 weeks of Pregabalin usage monthly headache frequency decreased to 2.2±4.5 and 1.76±6.2 respectively. Propranolol reduced monthly headache frequency up to 3.73±6.11 and 3.34±5.95 later 4 and 8 weeks respectively. There was a significant difference between these two groups according to headache frequency reduction (P=0.04). Pregabalin efficacy in reducing the frequency and duration of pediatric migraine headache is considerable in comparison with propranolol. https://acta.tums.ac.ir/index.php/acta/article/view/4892MigrainePreventive therapyPregabalinPropranolol
collection DOAJ
language English
format Article
sources DOAJ
author MohammadKazem Bakhshandeh Bali
Ali Akbar Rahbarimanesh
Manelie Sadeghi
Mostafa Sedighi
Parvaneh Karimzadeh
Mohammad Ghofrani
spellingShingle MohammadKazem Bakhshandeh Bali
Ali Akbar Rahbarimanesh
Manelie Sadeghi
Mostafa Sedighi
Parvaneh Karimzadeh
Mohammad Ghofrani
Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled Trial
Acta Medica Iranica
Migraine
Preventive therapy
Pregabalin
Propranolol
author_facet MohammadKazem Bakhshandeh Bali
Ali Akbar Rahbarimanesh
Manelie Sadeghi
Mostafa Sedighi
Parvaneh Karimzadeh
Mohammad Ghofrani
author_sort MohammadKazem Bakhshandeh Bali
title Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled Trial
title_short Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled Trial
title_full Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled Trial
title_fullStr Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled Trial
title_full_unstemmed Comparison of Propranolol and Pregabalin for Prophylaxis of Childhood Migraine: a Randomised Controlled Trial
title_sort comparison of propranolol and pregabalin for prophylaxis of childhood migraine: a randomised controlled trial
publisher Tehran University of Medical Sciences
series Acta Medica Iranica
issn 0044-6025
1735-9694
publishDate 2015-05-01
description Migraine involves 5-10% of children and adolescents. Thirty percent of children with severe migraine attacks have school absence and reduced quality of life that need preventive therapy. The purpose of this randomised control trial study is to compare the effectiveness, safety and the tolerability of pregabalin toward Propranolol in migraine prophylaxis of children. From May 2011 to October 2012, 99 children 3-15 years referred to the neurology clinic of Mofid Children's Hospital with a diagnosis of migraine enrolled the study. Patients randomly divided into two groups (A&B). We treated children of group A with capsule of pregabalin as children of group B with tablet of propranolol for at least 8 weeks. In this study, 99 patients were examined that 91 children reached the last stage. The group A consistsed of 46 patients, 12(26.1%) girls, 34 (73.9%) boys and the group B consisted of 45 patients, 14(31.1%) girls, 31 (68.9%) boys. Basis of age, gender, headache onset, headache frequency, migraine type, triggering and relieving factors there was no significant difference among these groups (P>0.05). After 4 and 8 weeks of Pregabalin usage monthly headache frequency decreased to 2.2±4.5 and 1.76±6.2 respectively. Propranolol reduced monthly headache frequency up to 3.73±6.11 and 3.34±5.95 later 4 and 8 weeks respectively. There was a significant difference between these two groups according to headache frequency reduction (P=0.04). Pregabalin efficacy in reducing the frequency and duration of pediatric migraine headache is considerable in comparison with propranolol.
topic Migraine
Preventive therapy
Pregabalin
Propranolol
url https://acta.tums.ac.ir/index.php/acta/article/view/4892
work_keys_str_mv AT mohammadkazembakhshandehbali comparisonofpropranololandpregabalinforprophylaxisofchildhoodmigrainearandomisedcontrolledtrial
AT aliakbarrahbarimanesh comparisonofpropranololandpregabalinforprophylaxisofchildhoodmigrainearandomisedcontrolledtrial
AT maneliesadeghi comparisonofpropranololandpregabalinforprophylaxisofchildhoodmigrainearandomisedcontrolledtrial
AT mostafasedighi comparisonofpropranololandpregabalinforprophylaxisofchildhoodmigrainearandomisedcontrolledtrial
AT parvanehkarimzadeh comparisonofpropranololandpregabalinforprophylaxisofchildhoodmigrainearandomisedcontrolledtrial
AT mohammadghofrani comparisonofpropranololandpregabalinforprophylaxisofchildhoodmigrainearandomisedcontrolledtrial
_version_ 1724740358101794816